FastWave Medical

Minneapolis, MN · Founded 2021 · Privately Held (backing)

Developer of intravascular devices designed for the arterial to be safe, efficacious, and cost-effective. FastWave Medical is based in Minneapolis, MN and was founded in 2021. Its last reported valuation was $30 million in May 2022. It has raised $40 million.

Last reported valuation
$30.0M
Oct 2026
Priced at
—
Total raised
$40.0M
Last round
—

FastWave Medical key facts

as of Oct 2026
  • Developer of intravascular devices designed for the arterial to be safe, efficacious, and cost-effective.
  • FastWave Medical is valued at approximately $30.0M as of Oct 2026 (last reported valuation).
  • It has raised $40.0M; the latest was Early Stage VC ($19.0M) in Dec 2024.
  • Notable investors include Epic Venture Partners, Grand Pharmaceutical Group, M&L Group, SCP Ventures.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$30.0M

FastWave Medical's last reported valuation, May 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of FastWave Medical with a free account
  • ·Watch FastWave Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

FastWave Medical funding rounds

No rounds on record

No funding rounds for FastWave Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

FastWave Medical valuation

FastWave Medical's last reported valuation was $30 million in May 2022. No priced round, secondary trade or fund mark has surfaced since.

FastWave Medical investors

4 investors are on record for FastWave Medical, including Epic Venture Partners, Grand Pharmaceutical Group, M&L Group and SCP Ventures.

About FastWave Medical

Developer of intravascular devices designed for the arterial to be safe, efficacious, and cost-effective. The company offers novel, secure, and cost-effective IVL catheters engineered for crossing complex lesions and tortuous anatomy, with reliable usability and a streamlined profile, angioplasty balloons provide smooth performance, enabling medical professionals to treat patients in a mannered way.

Sector
Healthcare
HQ
Minneapolis, MN, United States
Founded
2021
Employees
27
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.